Skip to content

CG Oncology CGON Free cash flow margin

Free cash flow margin at other companies

Pfizer logo
PfizerPFE
18%+8.8pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
18.5%-4.3pp
Gilead Sciences logo
Gilead SciencesGILD
34.4%+0.1pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-212%-95.8pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-250.1%-49.4pp
Exelixis logo
ExelixisEXEL
38.6%+2.9pp

Other financials

Income statement

See full
Revenue$1.1M+1,983%
Operating income-$66.4M-57.3%
Net income-$60.2M-74.7%
EPS (diluted)-$0.71-57.8%

Balance sheet

See full
Cash & equivalents$33.7M-18.7%
Total debt$7.6M+631%
Total equity$1.1B+54.9%
Total assets$1.1B+55.9%

Cash flow

See full
Operating cash flow-$56.9M-94.5%
CapEx$304.0K+1,800%
Free cash flow-$57.2M-95.4%

Valuation

See full
Market cap$5.39B+206%

Profitability

See full
Operating margin-4,239%-1,872pp
Net margin-3,682.6%-1,601pp

Returns & leverage

See full
Return on equity-20.8%+7.1pp
Debt / equity0.0×
Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

Based on trailing twelve months.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CG Oncology's free cash flow margin?
CG Oncology (CGON) reported free cash flow margin of -3,163.8% in Q1 2026.
How has CG Oncology's free cash flow margin changed year-over-year?
CG Oncology's free cash flow margin increased by 74.5% year-over-year, from -12,419.3% to -3,163.8%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.